- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Strong Balance Sheet Stocks
U.S. Pharmaceuticals & Biotech Strong Balance Sheet Stocks
UPDATED May 18, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
660 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
RNXT | US$1.37 | -5.5% | -36.3% | US$32.8m | US$3.75 | PB18.6x | E66.0% | n/a | ||
ACAD | US$14.79 | -3.0% | -39.2% | US$2.4b | US$27.16 | PS3x | E40.8% | n/a | ||
MNPR | US$0.61 | -9.3% | -34.4% | US$10.6m | US$2.08 | PB1.4x | E19.8% | n/a | ||
MGNX | US$4.37 | 31.9% | -24.1% | US$273.4m | US$13.00 | PS6.3x | E-18.4% | n/a | ||
ATOS | US$1.57 | 5.4% | 116.0% | US$197.4m | US$4.67 | PB2.3x | E68.0% | n/a | ||
CDXC | US$3.30 | -3.5% | 123.0% | US$249.2m | US$6.34 | PS3x | E99.5% | n/a | ||
PCVX | US$74.57 | 14.4% | 54.6% | US$8.1b | US$103.14 | PB4.1x | E1.3% | n/a | ||
CHRO | US$1.75 | -4.4% | n/a | US$10.3m | n/a | PB9.1x | n/a | n/a | ||
TRVI | US$2.77 | 1.5% | 15.4% | US$195.1m | US$7.40 | PB2.7x | E-9.1% | n/a | ||
VNDA | US$5.48 | 8.7% | -11.6% | US$318.9m | US$5.21 | PS1.8x | E30.9% | n/a | ||
NTLA | US$26.22 | 7.2% | -37.6% | US$2.5b | US$70.26 | PS48.1x | E33.1% | n/a | ||
RYZB | US$62.49 | 0% | n/a | US$3.7b | US$53.33 | PB6.5x | E2.0% | n/a | ||
NLTX | US$13.96 | 4.5% | 59.5% | US$32.8m | n/a | PB0.4x | n/a | n/a | ||
HZNP | US$116.30 | 0.06% | 82.8% | US$26.6b | US$116.50 | PE60.8x | E16.4% | n/a | ||
IDYA | US$40.50 | -1.6% | 86.0% | US$3.1b | US$52.82 | PS197.7x | E39.4% | n/a | ||
SNDX | US$20.29 | -6.7% | -6.5% | US$1.7b | US$34.17 | PB3.5x | E22.9% | n/a | ||
CRMD | US$5.12 | -1.0% | 0.4% | US$281.4m | US$13.00 | PB4.9x | E63.9% | n/a | ||
ZNTL | US$12.07 | -3.7% | -54.2% | US$857.1m | US$33.40 | PS21.1x | E8.5% | n/a | ||
TRDA | US$14.99 | 4.5% | 20.8% | US$476.0m | US$21.00 | PE20.3x | E-18.5% | n/a | ||
BEAM | US$24.62 | 15.8% | -28.7% | US$1.9b | US$48.38 | PS5.4x | E-14.3% | n/a | ||
CCCC | US$5.68 | -7.8% | 73.7% | US$390.8m | US$17.44 | PS19.5x | E60.4% | n/a | ||
IKNA | US$1.43 | 10.9% | -77.5% | US$69.0m | US$8.33 | PS17.9x | E-2.8% | n/a | ||
ENZN | US$0.095 | 9.4% | -40.8% | US$7.0m | n/a | PE31.9x | n/a | n/a | ||
OABI | US$4.45 | -4.9% | 15.3% | US$523.4m | US$9.88 | PS24.9x | E20.1% | n/a |